A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Clinical trial NCT05470140 · COMPLETED

Trial details

NCT number: NCT05470140
Sponsor: Allotera Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2023-07-01
Primary completion: 2024-10-08
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.